Simvastatin inhibits the adipogenesis of bone marrow-derived mesenchymal stem cells through the downregulation of chemerin/CMKLR1 signaling

Simvastatin is effective in the treatment of osteoporosis, partly through the inhibition of the adipogenesis of bone-marrow derived mesenchymal stem cells (BMSCs). The present study focused on the mechanisms responsible for the inhibitory effects of simvastatin on adipogenesis and examined the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yao, Huo, Jianzhong, Wu, Dou, Hao, Haihu, Ji, Xinghua, Zhao, Enzhe, Nie, Boyuan, Liu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307816/
https://www.ncbi.nlm.nih.gov/pubmed/32468037
http://dx.doi.org/10.3892/ijmm.2020.4606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307816/
https://www.ncbi.nlm.nih.gov/pubmed/32468037
http://dx.doi.org/10.3892/ijmm.2020.4606

Ejemplares similares